RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

Jan 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-01-24

Reporting Person: Duliege Anne-Marie (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-24	Employee Stock Option (right to buy)	$4.49	A	150000	Acquired	2028-01-24	Common Stock (150000)	Direct

Footnotes

F1: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018.